NCT04393506 2023-11-22
Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma
Shanghai Jiao Tong University School of Medicine
Phase 1 Completed
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Institut Claudius Regaud